Introduction
glands are the only affected organ in most patients; this observation suggests a selective sensitivity 81 of the adrenal glands to NNT loss (4, 5). Supportive of this, NNT-deficient mice harbor adrenal 82 glands with disorganized cortical architecture and high apoptotic rates in their adrenal zona 83 fasciculata, the location of glucocorticoid synthesis, but no other abnormality (4). 84
NNT is a dimeric proton pump that resides in the inner mitochondrial membrane of 85 eukaryotic cells and uses the transmembrane proton gradient to catalyze the transfer of reducing 86 equivalents from NADH to NADP + , according to the reaction 87 NADPH is an essential donor of reducing power to the two main mitochondrial antioxidant 89 pathways, the glutathione and the thioredoxin pathways, which protect the mitochondria from the 90 deleterious effects of oxidative stress with their capacity to detoxify reactive oxygen species (e.g. 91 hydrogen peroxide, H2O2). Reactive oxygen species (ROS), the molecular mediators of oxidative 92 stress, are continuously produced within the mitochondria by electron leakage along the respiratory 93 chain complexes and the tricarboxylic acid cycle (TCA); in adrenocortical mitochondria, 94 steroidogenesis represents an important additional source of ROS (8-11). Excessive levels of 95 oxidative stress lead to irreversible DNA, protein and lipid damage, which can culminate in 96 apoptotic cell death (Fig. 1A) (12) . 97
Drawing on these data, which indicate a distinct metabolic vulnerability of the adrenal 98 cortex to oxidative stress, we explored the value of antioxidant targeting as a novel therapeutic 99 approach in ACC, focusing on NNT as a putative treatment target. Interrogating a publicly 100 available whole genome gene expression database (13), we observed that NNT is up-regulated in 101
ACCs in comparison to benign adrenocortical adenomas and healthy adrenals (Fig. 1B) . 102 Therefore, we hypothesized NNT silencing in ACC cells will impair their antioxidant capacity and 103 lead to progressive accumulation of ROS, inducing unsustainable oxidative toxicity within the 104 mitochondria and eventually triggering cellular apoptosis. We also postulated that steroidogenesis 105 will be suppressed as a result of NADPH depletion and/ or increased oxidative stress. 106
Materials and Methods 107
Cell culture protocol and cell line validation 108 NCI-H295R (RRID:CVCL_0458) ACC cells (passage 10-25) were cultured under 109 standard conditions using DMEM/Ham's F-12 medium (Gibco, Thermo Fisher) supplemented 110 with 2.5% Nu serum (Corning), 1% penicillin-streptomycin (Gibco, Thermo Fisher) and 1% ITS+ 111 universal cell culture premix (Corning). Cell line identity was confirmed through Short Tandem 112
Repeat (STR) genetic analysis performed by the DNA Diagnostics Company (London, UK) 113 followed by comparison to genetic profiles provided by the American Tissue Culture Collection 114 (ATCC) (http://www.lgcstandards-atcc.org) (Suppl. Table 1) . 115
Small-interfering RNA (siRNA) transfection 116
Transient NNT gene silencing was achieved through transfection of NCI-H295R cells with 117 small interfering RNA (siRNA), using Viromer  Blue (Lipocalyx) molecules as transfection 118
vehicles. Three alternative siRNAs targeting different areas of the NNT gene were tried (Life 119
Technologies, HSS118900, HSS118901 and HSS118902), and the one exhibiting the most 120 consistent efficiency in knocking down NNT (HSS118902) was selected for subsequent 121 experiments. HSS118901 was used to corroborate results in proliferation and apoptosis assays, 122
whose results are open to confounding by off-target effects. A scrambled, non-sense siRNA 123 (Silencer Select 1 negative control, Life Technologies) was used as negative control (SCR siRNA). 124
Viromer-siRNA transfection was performed according to the manufacturer's instructions in 6-well 125 plates (300,000 cells/well) and 96-well plates (6-8,000 cells/well). Blotting for NNT expression. 138
Gene expression 139
Gene expression for NNT and steroidogenic enzymes was evaluated at a transcriptional level 140 by quantitative real-time polymerase chain reaction (qRT-PCR). RNA extraction was performed 141 using the RNeasy Mini kit (Qiagen) following the manufacturer's instructions. Reverse 142 transcription to generate complementary DNA (cDNA) was carried out using the TetrocDNA 143 Synthesis Kit (Bioline), following the manufacturer's instructions (500 -2,000 ng of RNA per 144 reaction used). cDNA concentration was determined by use of a fluorescent DNA dye (Quant-145 iT™ PicoGreen® dsDNA reagent, Thermo Fisher), comparing sample fluorescence to the 146 fluorescence exhibited by a dilution series of samples of known concentrations (Wallac Victor 147 1420 multilabel counter). Gene expression was then quantified by qRT-PCR, using the Taqman 148
Gene Expression System (Thermo Fisher). Reactions were run in a 7500 ABI qRT-PCR analyzer 149 
Protein expression 155
Protein lysate generation was performed by applying RIPA buffer (Sigma-Aldrich) with 156 protease inhibitor cocktail (Sigma-Aldrich) to adherent cells grown in 6-well plates and subsequent 157 collection by scraping. Total protein concentration was estimated colorimetrically using the BCA 158
Protein Assay Kit (Thermo Fisher) as per the manufacturer's instructions, measuring absorbance 159 at 560 nm (Wallac Victor 1420 multilabel counter). NNT protein expression level was assessed by 160
Western Blotting. Samples were run in 10% SDS-PAGE (polyacrylamide) Gels (Thermo Fisher) 161 and transferred to a nitrocellulose membrane using the iBLOT TM Dry Transfer System (Thermo 162 
Reduced to oxidized glutathione ratio (GSH/GSSG) 169
Total cell glutathione (GSH + GSSG) and oxidized glutathione (GSSG) were measured by 170 luminescence in cells growing in opaque-walled 96-well plates, using the GSH/GSSG-Glo Assay 171 
RNA sequencing 211
RNA was prepared in triplicate from NCI-H295R KD siRNA, SCR siRNA (72 hours post-212 transfection), KD shRNA and SCR shRNA cells using the RNeasy Mini kit (Qiagen). Libraries 213 were generated using the TruSeq Stranded mRNA Library Prep Kit (Illumina, USA). 4 nM library 214 (containing the 16 pooled libraries) was sequenced on a NextSeq500 System (Illumina). Pathway 215 analysis on sequencing data was completed using GAGE V2.22 package from Bioconductor 216 release 3.2 and referencing the KEGG pathways. Differentially expressed genes were considered 217 significant applying a false discovery rate of <5% (q<0.05). Differentially regulated pathways 218 were called at a p value of <0.01. A detailed description of the methodology for RNA sequencing 219 and pathway analysis can be found in Supplementary Methods. 220
In addition, RNA sequencing data from recently published work on three different mouse 221 strains (Nnt inactivating mutation, C57BL/6J (RRID:MGI:3702942) ; wild-type, C57BL/6NHsd 222 (RRID:MGI:2161078) ; and transgenic Nnt overexpressor, C57BL/6J BAC ) (16) were re-analyzed 223 employing the same pathway analysis as for the human cell-based model; detailed information on 224 this dataset can be found in Supplementary Methods. 225
Metabolome analysis 226
Cell and media samples were prepared for non-targeted metabolome analysis through 227 quenching cell metabolism with a mix of acetonitrile, methanol and water (Sigma-Aldrich). The 228 process of sample generation and analysis is described in more detail in the Supplementary 229
Methods. 230

Statistical analysis 231
Statistical analysis was performed using GraphPad Prism 7 Software 232 (RRID:SCR_002798). Data are represented as mean  SEM values, unless otherwise stated. 233
Comparisons were made using Student's paired t-test for normally distributed data or Wilcoxon's 234 signed-rank test for data not following a Gaussian distribution. Multiple comparisons (BSO and 235 auranofin treatments) were performed by one-way ANOVA followed by post-hoc multiple 236 comparison testing. Statistical methods for the RNA sequencing and untargeted metabolome 237 analysis are detailed in Supplementary Methods. 238
Results
239
Transient and stable NNT knockdown 240
Transient NNT silencing by siRNA knockdown was employed to explore the acute effects 241 of NNT loss on ACC cells. NNT siRNA transfection in NCI-H295R cells yielded efficient gene 242 silencing for at least 166 hours post-transfection with two different siRNAs (Suppl. Fig. 1A-B) . 243
All subsequent experiments were performed with the siRNA that gave the best knockdown results 244 on real-time PCR and Western Botting (referred to here as KD siRNA). The second siRNA (KD 245 siRNA2) was used to corroborate the results of proliferation and apoptosis assays, whose results 246 are most likely to be distorted by off-targets effects. 247
Stable NNT silencing by shRNA knockdown was used to delineate the long-term effects 248 of NNT loss on ACC cells. Stable NNT knockdown in NCI-H295R cells was achieved by lentiviral 249 transfection with shRNA-expressing plasmids and selection with puromycin, and resulted in 250 permanent NNT silencing (Suppl. Fig. 1C-D) . 251
NNT siRNA knockdown increases cellular oxidative stress 252
Given the central role of NNT within the mitochondrial ROS scavenging network, we 253 hypothesized that NNT knockdown will increase oxidative stress in NCI-H295R cells. To test this, 254
we measured the intracellular ratio of reduced to oxidized glutathione (GSH/GSSG), an established 255 marker of oxidative stress; a decrease in the GSH/GSSG ratio indicates that the proportion of 256 oxidized intracellular glutathione is increased as a result of higher intracellular ROS levels. Indeed, 257
we observed a statistically significant (p<0.05) decrease in the GSH/GSSG ratio in NNT KD 258 siRNA-transfected cells 96 hours post-transfection (Fig. 2A) . 259
NNT siRNA knockdown suppresses cell proliferation and induces apoptotic cell death 260
Cell proliferation rates were assessed over the time window from 72 to 166 hours post-261 transfection, a period with consistent NNT knockdown confirmed at protein level (Suppl . Fig. 1) . 262
NNT knockdown by KD siRNA transfection led to a marked decrease in cellular proliferation rates 263 (Fig. 2B) . These results were corroborated by use of a second siRNA against NNT, which 264 completely obliterated cell proliferation (Suppl . Fig. 2) . 265
To establish whether the increased oxidative stress observed with NNT KD leads to higher 266 rates of apoptosis -as predicted by ROS physiology-we measured intracellular caspase 3 and 7 267 activity 120 hours post-transfection. We also quantified relative cell numbers by DNA 268 fluorescence at the same time-point to standardize results to cell number. NNT KD siRNA cells 269 exhibited significantly higher caspase 3/7 activity than SCR siRNA cells (p<0.05), confirming our 270 hypothesis that NNT knockdown triggers cell death by apoptosis (Fig. 2C) . The effect was even 271 more marked with the alternative siRNA against NNT (Suppl. Fig. 2) . 272
NNT siRNA knockdown sensitizes cells to oxidative stress 273
Next, we evaluated changes in mitochondrial respiration by direct measurement of the 274 cellular oxygen consumption rate (OCR), using Extracellular Flux analysis. Despite the location 275 of NNT in the inner mitochondrial membrane, we observed no statistically significant difference 276 between NNT KD siRNA-and SCR siRNA-transfected cells, either at baseline or in response to 277 mitochondrial respiration disruptors (Fig. 2D) . Baseline extracellular acidification rate (ECAR), 278 representative of the glycolytic rate, was also similar between the two groups (Fig. 2E) . 279
Considering the integral role of NNT in mitochondrial antioxidant defense and the 280 detrimental impact of NNT inhibition on redox balance, we further hypothesized that NNT loss 281 will render NCI-H295R cells more sensitive to chemically induced oxidative stress. To assess this 282 assumption, we treated NCI-H295R cells with a sub-toxic dose of paraquat, a pesticide which 283 induces oxidative stress in vitro generating superoxide. Treatment with 10 μM of paraquat for 96 284 hours led to a statistically significant decrease in cell proliferation in cells transfected with KD 285 siRNA, but not in their counterparts that had been transfected with SCR siRNA (Fig. 2F) . 286
Redox adaptation develops with stable NNT knockdown 287
To explore the long-term metabolic consequences of NNT silencing in NCI-H295R cells, 288
we employed a different model, involving stable transfection with shRNA against NNT. With 289 long-term culture under persistent NNT silencing (4-12 weeks post-transfection), cells managed 290 to restore their redox balance to the levels of their SCR shRNA-transfected counterparts (Fig. 3A) . 291
ACC proliferation remains suppressed with stable NNT knockdown 292
The distinct metabolic consequences of NNT silencing in the stable knockdown setting, in 293 comparison to acute knockdown by NNT siRNA, translated into an attenuated response with 294 respect to cellular proliferation and viability. Proliferation rates remained significantly lower in 295 KD shRNA-transfected cells compared to the SCR shRNA-transfected controls; however, this was 296 less pronounced than the decrease in proliferation we observed with siRNA-mediated knockdown 297 (Fig. 3B) . Apoptotic rates did not differ between SCR shRNA and KD shRNA cells (Fig. 3C) , in 298 keeping with the restoration of redox homeostasis we had ascertained based on the reduced/ 299 oxidized glutathione ratio. 300
Interestingly, NNT KD shRNA cells consumed more oxygen than SCR shRNA cells at 301 baseline (Fig. 3D) . This finding potentially reflects higher energy needs in NNT deficient cells. 302
The same trend was observed in ECAR, a surrogate marker of glycolysis, but without reaching 303 statistical significance (Fig. 3E) . Finally, stable NNT knockdown did not enhance cell sensitivity 304 to oxidative stress induced by paraquat. (Fig. 3F) . 305
Transient, but not stable, NNT knockdown paradoxically stimulates steroidogenesis 306
The effects of NNT silencing on steroidogenesis were evaluated by comprehensive multi-307 steroid profiling in cell media by LC-MS/MS, as well as gene expression analysis by qRT-PCR. 308
We postulated that NNT silencing will disrupt steroidogenesis, either depriving mitochondrial 309 steroidogenic monooxygenases [cholesterol side-chain cleaving enzyme (CYP11A1), 11-310 hydroxylase (CYP11B1), aldosterone synthase (CYP11B2)] of their essential electron donor 311 NADPH, or due to oxidative stress-induced down-regulation of key steroidogenic enzymes. 312 Surprisingly, NNT KD siRNA-transfected cells actually produced significantly more 313 glucocorticoids (cortisol) and androgens (androstenedione) than controls (Fig. 4A-B) . Individual 314 enzyme activities were determined as product-to-substrate ratios for three key steroidogenic 315 enzymes, 11-hydroxylase (CYP11B1), 21-hydroxylase (CY21A2), and CYP17A1 17/20-lyase 316 activity; all three displayed higher activity in NNT KD siRNA-transfected cells, in keeping with a 317 paradoxical generalized stimulation of steroidogenesis by acute NNT loss (Fig. 4C-E) . 318
By contrast, in the shRNA-transfected cells with chronic NNT silencing we observed no 319 significant impact on steroidogenesis, with similar rates of cortisol or androstenedione synthesis 320 between KD shRNA and SCR shRNA cells (Fig. 4A-E) . 321
We also explored the gene expression alterations underpinning the enhanced steroid 322 production of cells transfected with KD siRNA, comparing the expression of core steroidogenic 323 genes (StAR, CYP11A1, CYP21A2, CYP17A1, 3βHSD2) between KD siRNA and SCR siRNA 324 cells by qRT-PCR. There was a statistically significant increase in the expression of cytochrome 325 P450 (CYP) type 2 steroidogenic enzymes located in the ER CYP21A2 (p<0.05), CYP17A1 326 (p<0.05), as well as the ER dehydrogenase HSD3B2 (p<0.01) in NNT KD siRNA cells (Suppl. 327 Table 2 ). CYP11B1 and CYP11B2 expression levels were too low to be quantified by qRT-PCR 328 in our cells. 329 Analysis of gene expression by RNA sequencing in an extended panel of 14 steroidogenic 330 genes indicated a significant up-regulation of CYP21A2 (q<0.05) and CYP17A1 (q<0.01), as well 331 as the ACTH receptor MC2R (q<0.01) in the transient NNT knockdown model; no significant 332 changes were observed in the stable knockdown model (Fig. 4F) . 333
NCI-H295R cells are sensitive to glutathione depletion and thioredoxin reductase inhibition 334
Given the effects of NNT inhibition on NCI-H295R cell proliferation, we went on to 335 evaluate the sensitivity of ACC cells to isolated inhibition of each of the two pillars of 336 mitochondrial antioxidant defense: the glutathione pathway and the thioredoxin pathway. 337
We used buthionine sulfoximine (BSO), a potent inhibitor of the glutathione-producing 338 enzyme c-glutamylcysteine ligase, to deplete intracellular glutathione. We observed a decline in 339 cell proliferation with a BSO dose of 100 M after 96 hours of treatment (Fig. 5A) . 340
Pharmacological manipulation of the alternative mitochondrial antioxidant pathway, the 341 thioredoxin pathway, was achieved by auranofin, a gold complex agent with a well-established 342 capacity to inhibit thioredoxin reductase. NCI-H295R treatment with doses of 1 M was 343 associated with major cytotoxity (Fig. 5B) . 344
Finally, dual inhibition of the glutathione and thioredoxin pathways by co-administration 345 of low-dose BSO (50 M) and auranofin (0.2 M) resulted in marked cytotoxicity, suggesting that 346 a potent synergistic effect can be achieved by dual pathway targeting (Fig. 5C) . 347
Whole transcriptome and metabolome analyses reveal extensive metabolic perturbations with 348 transient NNT knockdown, as well as changes in protein processing and polyamine metabolism 349 with stable NNT knockdown 350
In order to uncover the molecular mechanisms that underpin the effects we observed in the 351 two models and the discrepancies between them, we applied whole transcriptome analysis in RNA In the stable NNT shRNA knockdown model, pathway enrichment analysis highlighted 395 changes in purine metabolism (q<0.05) and NNT knockdown cells exhibited a significant (p<0.05) 396 rise in several purine and pyrimidine metabolites (Fig. 6D and Suppl. Tables 6 and 7) , mirroring 397 the results of the transcriptome analysis. Polyamine (spermine, spermidine) metabolism was also 398 significantly modified in both models: KD siRNA cells displayed a dramatic increase in polyamine 399 catabolism (accumulation of diacetyl-spermine, diacetyl-spermidine, spermine dialdehyde) 400 leading to depletion of spermine and spermidine, a response that has been associated with arrest 401 of cell growth (Suppl. Tables 6 and 7) (19). Conversely, KD shRNA cells exhibited a significant 402 rise in spermine, a polyamine that can act as a ROS scavenger (20, 21). 403
Discussion 404
With this work, we have explored the immediate and longer-term impact of NNT silencing 405 on ACC cells with respect to redox balance, mitochondrial bioenergetics, cell proliferation and 406 viability, and steroidogenesis, using two distinct in vitro knockdown models in the human 407 adrenocortical carcinoma cell line NCI-H295R. Our aim was to establish whether NNT inhibition 408 can have therapeutically beneficial effects with respect to control of tumor growth and steroid 409 excess. We hypothesized that NNT inhibition would compromise the ability of adrenocortical 410 mitochondria to deal with oxidative stress, leading to progressive accumulation of ROS. ROS 411 excess has multiple toxic sequelae, and can directly impair cell viability triggering apoptosis (8, 412 12). Importantly, the adrenal-specific clinical phenotype in humans and the reported increased rate 413 of adrenocortical cell apoptosis in otherwise healthy NNT mutant mice suggest that this 414 manipulation may selectively target ACC cells, sparing other organs. This susceptibility of 415 adrenocortical cells to mitochondrial antioxidant pathway disruption can be explained by the fact 416 that enzymes involved in the rapid adrenal steroid response to stress represent a major additional 417 source of ROS in the adrenals, increasing their dependence on efficient ROS scavenging (10, 11). 418
In keeping with our hypothesis, we found that in the acute setting (siRNA-mediated 419 These findings are in line with the biological role of NNT as a major mitochondrial generator of 423 NADPH, the essential provider of reducing equivalents to the two main antioxidant pathways (26). 424
Importantly, in our study we observed that NNT silencing led to an immediate and marked 425 inhibition of cell proliferation accompanied by increased apoptotic rates. This anti-tumor effect 426 was even more pronounced when using a second anti-NNT siRNA (KD siRNA2). This apparent 427 difference in degree (but not in direction) of cell response raised the possibility of additional, off- Within the same framework, we also explored alternative antioxidant targets focusing on 492 the glutathione and thioredoxin pathways. Pertinently, human mutations in thioredoxin reductase 493 2 have also been shown to result in isolated glucocorticoid deficiency (37). We used BSO to inhibit 494 glutathione synthesis. BSO has shown anti-proliferative effects against a number of cell lines in 495 vitro (38-43). We observed a significant suppression of cell growth with doses of 100 M, i.e.
496
at doses that are clinically attainable in plasma with no serious toxicity (38). Auranofin, a gold 497 complex-based agent able to inhibit thioredoxin reductase, also suppressed cell proliferation at 498 doses 1M and was associated with marked cytotoxicity at doses of  2 M. Auranofin has also 499 displayed anti-tumor activity against a number of cell lines in vitro and is currently being 500 investigated in clinical trials against leukemia (44-47). Applying combined treatment with low 501 doses of both agents, we observed a dramatic cytotoxic impact, suggesting that dual antioxidant 502 targeting can achieve potent synergistic results. 503
The observed effects of NNT silencing on NCI-H295R steroidogenesis were surprising. In 504 the acute setting, i.e. NNT siRNA knockdown, we observed a generalized stimulation of 505 steroidogenesis, leading to increased glucocorticoid and adrenal androgen output by the cells. indicating that the direction of the effect is dose-dependent (51) . 517
Taken together, we show that NNT silencing can induce cytotoxicity and impede cell 518 growth in adrenocortical carcinoma cells, as well as sensitize them to chemically-induced 519 oxidative stress. Moreover, we have demonstrated how the plasticity of ACC cells can lead to the 520 development of a compensatory molecular response with time and described how changes in 521 polyamine metabolism and ER protein processing are involved in this process (Fig. 7) . A limitation 522 of our work is that it is based on a single cell line; however, NCI-H295R remains the only 523 established, well characterized steroidogenic human ACC cell line. These results merit further 524 exploration with in vivo studies to corroborate the effectiveness of mitochondrial anti-oxidant 525 pathway targeting and explore its durability, alone or in combination with other pro-oxidant agents. 526
The unique features of adrenocortical cells, with their high-volume ROS generation due to 527 steroidogenesis, make ACC a most amenable target to this approach. Fig. 1 
